Filed: 5/15/2023ACC: 0001420506-23-001113
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 91 equity positions with a total reported market value of $180.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
91
Positions
$180.15M
Total AUM (reported)
44.57M
Total Shares
Allocation by class
COM$117.46M65.2%
COM NEW$22.29M12.4%
CALL$12.80M7.1%
CL A$6.33M3.5%
COMMON STOCK$4.62M2.6%
SPONSORED ADR$4.58M2.5%
CLASS A COM$2.59M1.4%
Portfolio Concentration
Top 3$37.13M20.6%
4–10$39.81M22.1%
11–25$54.18M30.1%
Rest$49.03M27.2%
Top 3 weight
20.6%
Top 10 weight
42.7%
Voting Authority Distribution
Total shares with voting rights: 44.57M
Sole
Full voting authority
44.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole91
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings91
Rows:
ASTRIA THERAPEUTICS INC
SOLEShares1.35M
TypeSH
Market value$17.92M
9.95%
Sole
1.35M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares161.50K
TypeSH
Market value$9.71M
5.39%
Sole
161.50K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares2.87M
TypeSH
Market value$9.50M
5.27%
Sole
2.87M
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares1.13M
TypeSH
Market value$8.15M
4.52%
Sole
1.13M
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares305K
TypeSH
Market value$7.06M
3.92%
Sole
305K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares185K
TypeSH
Market value$5.43M
3.01%
Sole
185K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares620K
TypeSH
Market value$5.41M
3.00%
Sole
620K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares150K
TypeSH
Market value$4.62M
2.57%
Sole
150K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares500K
TypeSH
Market value$4.58M
2.54%
Sole
500K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares91K
TypeSH
Market value$4.56M
2.53%
Sole
91K
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares16K
TypeSH
Market value$4.46M
2.48%
Sole
16K
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares270K
TypeSH
Market value$4.21M
2.34%
Sole
270K
Shared
0.00
None
0.00
MYRIAD GENETICS INC
SOLEShares180K
TypeSH
Market value$4.18M
2.32%
Sole
180K
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares240K
TypeSH
Market value$4.18M
2.32%
Sole
240K
Shared
0.00
None
0.00
AKOYA BIOSCIENCES INC
SOLEShares500K
TypeSH
Market value$4.09M
2.27%
Sole
500K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares6.23M
TypeSH
Market value$3.97M
2.20%
Sole
6.23M
Shared
0.00
None
0.00
RESMED INC
SOLEShares17K
TypeSH
Market value$3.72M
2.07%
Sole
17K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares850K
TypeSH
Market value$3.57M
1.98%
Sole
850K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares260K
TypeSH
Market value$3.55M
1.97%
Sole
260K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares35K
TypeSH
Market value$3.18M
1.77%
Sole
35K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares130K
TypeSH
Market value$3.16M
1.76%
Sole
130K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares750.10K
TypeSH
Market value$3.08M
1.71%
Sole
750.10K
Shared
0.00
None
0.00
VAREX IMAGING CORP
SOLEShares165K
TypeSH
Market value$3.00M
1.67%
Sole
165K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares12.50K
TypeSH
Market value$2.93M
1.62%
Sole
12.50K
Shared
0.00
None
0.00
KORU MEDICAL SYSTEMS INC
SOLEShares685K
TypeSH
Market value$2.89M
1.60%
Sole
685K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASTRIA THERAPEUTICS INCSOLE | COM | 1.35M | SH | $17.92M 9.95% | 1.35M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | CALL | 161.50K | SH | $9.71M 5.39% | 161.50K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 2.87M | SH | $9.50M 5.27% | 2.87M | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 1.13M | SH | $8.15M 4.52% | 1.13M | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 305K | SH | $7.06M 3.92% | 305K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 185K | SH | $5.43M 3.01% | 185K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 620K | SH | $5.41M 3.00% | 620K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 150K | SH | $4.62M 2.57% | 150K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 500K | SH | $4.58M 2.54% | 500K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 91K | SH | $4.56M 2.53% | 91K | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 16K | SH | $4.46M 2.48% | 16K | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | COM NEW | 270K | SH | $4.21M 2.34% | 270K | 0.00 | 0.00 |
MYRIAD GENETICS INCSOLE | COM | 180K | SH | $4.18M 2.32% | 180K | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | COM NEW | 240K | SH | $4.18M 2.32% | 240K | 0.00 | 0.00 |
AKOYA BIOSCIENCES INCSOLE | COM | 500K | SH | $4.09M 2.27% | 500K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 6.23M | SH | $3.97M 2.20% | 6.23M | 0.00 | 0.00 |
RESMED INCSOLE | COM | 17K | SH | $3.72M 2.07% | 17K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 850K | SH | $3.57M 1.98% | 850K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 260K | SH | $3.55M 1.97% | 260K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 35K | SH | $3.18M 1.77% | 35K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 130K | SH | $3.16M 1.76% | 130K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | CALL | 750.10K | SH | $3.08M 1.71% | 750.10K | 0.00 | 0.00 |
VAREX IMAGING CORPSOLE | COM | 165K | SH | $3.00M 1.67% | 165K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 12.50K | SH | $2.93M 1.62% | 12.50K | 0.00 | 0.00 |
KORU MEDICAL SYSTEMS INCSOLE | COM | 685K | SH | $2.89M 1.60% | 685K | 0.00 | 0.00 |
Page 1 of 4